U.S. flag

An official website of the United States government

NM_000157.4(GBA1):c.1297G>T (p.Val433Leu) AND Gaucher disease type III

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jan 1, 1991
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000004520.11

Allele description [Variation Report for NM_000157.4(GBA1):c.1297G>T (p.Val433Leu)]

NM_000157.4(GBA1):c.1297G>T (p.Val433Leu)

Genes:
LOC106627981:GBA recombination region [Gene]
GBA1:glucosylceramidase beta 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1q22
Genomic location:
Preferred name:
NM_000157.4(GBA1):c.1297G>T (p.Val433Leu)
Other names:
V394L
HGVS:
  • NC_000001.11:g.155235772C>A
  • NG_009783.1:g.13926G>T
  • NG_042867.1:g.2234C>A
  • NM_000157.4:c.1297G>TMANE SELECT
  • NM_001005741.3:c.1297G>T
  • NM_001005742.3:c.1297G>T
  • NM_001171811.2:c.1036G>T
  • NM_001171812.2:c.1150G>T
  • NP_000148.2:p.Val433Leu
  • NP_001005741.1:p.Val433Leu
  • NP_001005742.1:p.Val433Leu
  • NP_001165282.1:p.Val346Leu
  • NP_001165283.1:p.Val384Leu
  • NC_000001.10:g.155205563C>A
  • NM_000157.3:c.1297G>T
  • NM_001005741.2:c.1297G>T
  • NM_001005741.3:c.1297G>T
  • NM_001005742.2:c.1297G>T
  • P04062:p.Val433Leu
  • c.1297G>T (p.Val433Leu)
Protein change:
V346L; VAL394LEU
Links:
UniProtKB: P04062#VAR_003310; OMIM: 606463.0005; dbSNP: rs80356769
NCBI 1000 Genomes Browser:
rs80356769
Molecular consequence:
  • NM_000157.4:c.1297G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001005741.3:c.1297G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001005742.3:c.1297G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001171811.2:c.1036G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001171812.2:c.1150G>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Gaucher disease type III
Synonyms:
GD III; GD 3; Gaucher disease, juvenile and adult, cerebral; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0009267; MedGen: C0268251; Orphanet: 355; Orphanet: 77261; OMIM: 231000

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV000024694OMIM
no assertion criteria provided
Pathogenic
(Jan 1, 1991) 		germlineliterature only

PubMed (2)
[See all records that cite these PMIDs]

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Gaucher disease: molecular heterogeneity and phenotype-genotype correlations.

Theophilus B, Latham T, Grabowski GA, Smith FI.

Am J Hum Genet. 1989 Aug;45(2):212-25.

PubMed [citation]
PMID:
2502917
PMCID:
PMC1683351

Heterogeneity of mutations in the acid beta-glucosidase gene of Gaucher disease patients.

Latham TE, Theophilus BD, Grabowski GA, Smith FI.

DNA Cell Biol. 1991 Jan-Feb;10(1):15-21.

PubMed [citation]
PMID:
1899336

Details of each submission

From OMIM, SCV000024694.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (2)

Description

Theophilus et al. (1989) and Latham et al. (1990) identified a heterozygous 5912G-T transversion in the GBA gene, resulting in a val394-to-leu (V394L) substitution, in an Ashkenazi Jewish/Irish patient with Gaucher disease type III (231000) and an Ashkenazi Jewish patient with Gaucher disease type I (230800). The patient with type III disease was compound heterozygous for the V394L substitution on 1 allele and a complex substitution (606463.0009) and D409H (606463.0006) on the other allele. He developed psychomotor retardation and myoclonic seizures by age 5 years and died at 6 years. The patient with type I disease was compound heterozygous for V394L and N370S (606463.0003). Latham et al. (1990) suggested that the N370S allele protected the type I patient from the development of neuronopathic disease.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 10, 2024